Explorer
Coronavirus third wave 'dangerous' for kids, vaccine trial approved
Bharat Biotech International Ltd (BBIL) had proposed to carry out a Phase II-III clinical trial of Covaxin in the age group of two to 18 years.
As rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (Covid-19) on May 11 this year. Coronavirus' third wave can be 'dangerous' for kids, so the necessary steps are being taken care of
India
Breaking: Suvendu Adhikari Files Nomination from Bhabanipur Amid Amit Shah’s Roadshow
Breaking News: Massive Blaze Erupts in Surat Nylon Factory, Thick Smoke Engulfs Area, Firefighting Underway
Market Rally: Sensex Surges 1700 Points, Nifty Jumps 500 on Easing War Tension Signals
India LPG Shock: Commercial Cylinder Prices Surge Amid Global War and Hormuz Supply Crisis
POLITICAL ACE: Former Tennis Star Leander Paes Joins BJP Ahead of Bengal Elections
View More
Top Headlines
World
Kash Patel To Be Fired Next? Ex-FBI Agent Makes Big Claim After Trump Sacks Pam Bondi
World
'Haven't Even Started': Trump's Fresh Warning To Iran After B1 Bridge Attack
Science
NASA’s Artemis II Breaks Free Of Earth Orbit, Astronauts Rocket Toward Moon
World
China Opposes Use Of Force In Middle East, Warns It Would 'Legitimise Unlawful' Action: UN Envoy
Trending News
